Kosaka M, Fujino H, Tsuge M, Yamaoka K, Fujii Y, Uchikawa S
J Gastroenterol. 2025; .
PMID: 39841247
DOI: 10.1007/s00535-025-02211-5.
Paturel A, Casuscelli di Tocco F, Bousquet D, Plissonnier M, Grand X, Tak H
JHEP Rep. 2024; 6(10):101124.
PMID: 39328324
PMC: 11424956.
DOI: 10.1016/j.jhepr.2024.101124.
Liu J, Yu Y, Zhao H, Guo L, Yang W, Yan Y
Eur J Med Res. 2024; 29(1):343.
PMID: 38902822
PMC: 11191257.
DOI: 10.1186/s40001-024-01942-0.
Yuen M, Chuang W, Peng C, Jeng W, Su W, Chang T
Clin Mol Hepatol. 2024; 30(3):375-387.
PMID: 38528825
PMC: 11261219.
DOI: 10.3350/cmh.2023.0535.
Yi S, Ren G, Zhu Y, Cong Q
Virol J. 2024; 21(1):22.
PMID: 38243304
PMC: 10799397.
DOI: 10.1186/s12985-023-02277-8.
HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients.
Xu Z, Xu Y, Wu Z, Wang S, Zhang M, Jiang Y
Sci Rep. 2024; 14(1):1502.
PMID: 38233602
PMC: 10794194.
DOI: 10.1038/s41598-024-52060-0.
A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients.
Song K, Zeng D, Zheng Y, Zhang H, Weng Z, Zhou Y
Front Med (Lausanne). 2023; 10:1243202.
PMID: 38089868
PMC: 10711601.
DOI: 10.3389/fmed.2023.1243202.
HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients.
Song G, Yang R, Jin Q, Liu J, Rao H, Feng B
BMC Gastroenterol. 2023; 23(1):381.
PMID: 37946120
PMC: 10634007.
DOI: 10.1186/s12876-023-03023-8.
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Testoni B, Scholtes C, Plissonnier M, Paturel A, Berby F, Facchetti F
Gut. 2023; 73(4):659-667.
PMID: 37879886
PMC: 10958289.
DOI: 10.1136/gutjnl-2023-330644.
Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses.
Xu Q, Ding H, Bai T, Huang R, Wang J, Zhang J
J Mol Histol. 2023; 54(6):739-749.
PMID: 37843699
DOI: 10.1007/s10735-023-10162-5.
Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNA.
Hu X, Zhao L, Ou M, Chen Y, Wei H, Xia Y
Heliyon. 2023; 9(8):e18557.
PMID: 37560627
PMC: 10407120.
DOI: 10.1016/j.heliyon.2023.e18557.
Past, present, and future of long-term treatment for hepatitis B virus.
Broquetas T, Carrion J
World J Gastroenterol. 2023; 29(25):3964-3983.
PMID: 37476586
PMC: 10354584.
DOI: 10.3748/wjg.v29.i25.3964.
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis.
Schollmeier A, Glitscher M, Hildt E
Int J Mol Sci. 2023; 24(5).
PMID: 36902395
PMC: 10003785.
DOI: 10.3390/ijms24054964.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Janssen H, Hou J, Asselah T, Chan H, Zoulim F, Tanaka Y
Gut. 2023; 72(7):1385-1398.
PMID: 36697207
PMC: 10313999.
DOI: 10.1136/gutjnl-2022-328041.
The role of different viral biomarkers on the management of chronic hepatitis B.
Mak L, Hui R, Fung J, Seto W, Yuen M
Clin Mol Hepatol. 2023; 29(2):263-276.
PMID: 36655304
PMC: 10121282.
DOI: 10.3350/cmh.2022.0448.
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens.
Gish R, Asselah T, Squires K, Mayers D
Antivir Chem Chemother. 2022; 30:20402066221138705.
PMID: 36423233
PMC: 9703507.
DOI: 10.1177/20402066221138705.
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B.
Zhang S, Zhang X, Jin H, Dou Y, Li L, Yuan X
J Clin Transl Hepatol. 2022; 11(1):67-75.
PMID: 36406311
PMC: 9647108.
DOI: 10.14218/JCTH.2022.00066.
Current treatment of chronic hepatitis B: Clinical aspects and future directions.
Zhu M, Wang H, Lou T, Xiong P, Zhang J, Li L
Front Microbiol. 2022; 13:975584.
PMID: 36160238
PMC: 9493448.
DOI: 10.3389/fmicb.2022.975584.
The Prognostic Value of Serum HBV-RNA during Hepatitis B Virus Infection is Related to Acute-on-Chronic Liver Failure.
Qian K, Xue Y, Sun H, Lu T, Wang Y, Shi X
Can J Gastroenterol Hepatol. 2022; 2022:8422242.
PMID: 36148157
PMC: 9489391.
DOI: 10.1155/2022/8422242.
The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study.
Ye F, Zhao W, Yang X, Zhang X, An X, Zhu R
Ann Transl Med. 2022; 10(16):897.
PMID: 36110993
PMC: 9469125.
DOI: 10.21037/atm-22-3265.
